Teva and Alvotech Unveil Revolutionary Biosimilar of Stelara with 85% Price Slash: A Game Changer for Immunosuppressive Treatments! Frank Dolan February 21, 2025
Navigating the Turbulent Waters of Biotech: Opportunities Amidst Challenges Following Robert F. Kennedy Jr.’s Appointment Frank Dolan February 20, 2025
Roche Revolutionizes Pharmacogenomics with Four-Hour Genome Sequencing: A Game Changer for Accurate Diagnosis and Treatment! Frank Dolan February 20, 2025
Navigating the Storm: Biopharma Layoffs in 2024 – Reflections, Insights and Updates Frank Dolan February 19, 2025
Revolutionizing Biology: Nvidia and Arc Institute Unveil Evo 2 AI Model Frank Dolan February 19, 2025
Novo Nordisk Seeks $830 Million in Damages: Court Freezes KBP Biosciences’ Assets Amid Licensing Dispute Frank Dolan February 18, 2025
Mergers & Acquisitions Surge in Biotech: Factors Behind the 2025 Boom and Future Outlook Frank Dolan February 17, 2025
Pharmaceutical News Roundup: Kennedy’s New Role at HHS, Major Deals & M&A Insights Frank Dolan February 17, 2025
Surge in Biotech Mergers & Acquisitions: What 2025 Holds for the Pharma Industry Frank Dolan February 14, 2025
Renee Wegrzyn Ousted from ARPA-H: Inside the Trump Administration’s Health Agency Reshuffle Frank Dolan February 14, 2025
Top 14 Biotech Podcasts to Follow in 2025: Stay Ahead in the Rapidly Evolving Biotechnology Industry! Frank Dolan February 13, 2025
Revolutionizing Drug Development: How David Baker’s Lab is Using AI to Engineer De Novo Enzymes for Advanced Gene Editing Frank Dolan February 13, 2025
Biotech Stocks in Turmoil: How Robert F. Kennedy Jr.’s Appointment is Shaking Up the Market Frank Dolan February 12, 2025
CVS Health’s Financial Struggles: How New CEO David Joyner Plans to Tackle Rising Medical Costs Frank Dolan February 12, 2025
Biotech & Pharma Stocks to Watch: Investment Insights and Market Trends Frank Dolan February 11, 2025
FDA Alerts US Import of Chinese API Manufacturers Over Serious Quality Control Failures Frank Dolan February 11, 2025
22 Attorneys General Unite Against Trump Administration’s NIH Grant Cost Cap: A Threat to University Funding Frank Dolan February 10, 2025
Top 14 Biotech Podcasts to Follow in 2025: Your Guide to the Future of Biotechnology Frank Dolan February 7, 2025
Trade Group of 1,600 Hospitals Opposes Eli Lilly’s 340B Rebate Model: A Call to Action Frank Dolan February 7, 2025
